» Articles » PMID: 17637681

Liver Cancer Risk, Coffee, and Hepatitis C Virus Infection: a Nested Case-control Study in Japan

Overview
Journal Br J Cancer
Specialty Oncology
Date 2007 Jul 20
PMID 17637681
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

We examined hepatocellular carcinoma mortality in relation to coffee consumption and anti-hepatitis C virus (HCV) antibody seropositivity in a nested case-control study involving 96 cases. The multivariate-adjusted odds ratios (95% confidence interval) for daily coffee drinkers vs non-drinkers were 0.49 (0.25-0.96), 0.31 (0.11-0.85), and 0.75 (0.29-1.92) in all cases, in HCV-positive and in HCV-negative individuals, respectively.

Citing Articles

Regular coffee intake improves liver enzyme levels and liver histology in patients with chronic alcohol consumption, non-alcoholic fatty liver and non-alcoholic steatohepatitis: Report of 259 cases.

Degertekin B, Tozun N, Soylemez A, Gurtay E, Bozkurt U, Yilmaz Y Hepatol Forum. 2022; 1(3):88-96.

PMID: 35949725 PMC: 9349493. DOI: 10.14744/hf.2020.2020.0026.


Coffee Drinking and Reduced Risk of Liver Cancer: Update on Epidemiological Findings and Potential Mechanisms.

Inoue M, Tsugane S Curr Nutr Rep. 2019; 8(3):182-186.

PMID: 30977056 DOI: 10.1007/s13668-019-0274-1.


Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review.

Axley P, Ahmed Z, Ravi S, Singal A J Clin Transl Hepatol. 2018; 6(1):79-84.

PMID: 29607308 PMC: 5863002. DOI: 10.14218/JCTH.2017.00067.


Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.

Kennedy O, Roderick P, Buchanan R, Fallowfield J, Hayes P, Parkes J BMJ Open. 2017; 7(5):e013739.

PMID: 28490552 PMC: 5730000. DOI: 10.1136/bmjopen-2016-013739.


An updated dose-response meta-analysis of coffee consumption and liver cancer risk.

Yu C, Cao Q, Chen P, Yang S, Deng M, Wang Y Sci Rep. 2016; 6:37488.

PMID: 27910873 PMC: 5133591. DOI: 10.1038/srep37488.


References
1.
Inoue M, Yoshimi I, Sobue T, Tsugane S . Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst. 2005; 97(4):293-300. DOI: 10.1093/jnci/dji040. View

2.
Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H . Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer. 2005; 93(5):607-10. PMC: 2361599. DOI: 10.1038/sj.bjc.6602737. View

3.
Tamakoshi A, Yoshimura T, Inaba Y, Ito Y, Watanabe Y, Fukuda K . Profile of the JACC study. J Epidemiol. 2005; 15 Suppl 1:S4-8. PMC: 8565873. DOI: 10.2188/jea.15.s4. View

4.
Hasegawa M, Yamada S, Hirayama C . Fasting plasma caffeine level in cirrhotic patients: relation to plasma levels of catecholamines and renin activity. Hepatology. 1989; 10(6):973-7. DOI: 10.1002/hep.1840100614. View

5.
Ohfuji S, Fukushima W, Tanaka T, Habu D, Tamori A, Sakaguchi H . Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study. Hepatol Res. 2006; 36(3):201-8. DOI: 10.1016/j.hepres.2006.07.010. View